Evotec SE Announces New Nomination to Board of Directors and Cooperation Agreement with MAK Capital

Evotec SE has announced the nomination of Dr. Wolfgang Hofmann for election as an independent member of the Supervisory Board at the upcoming Annual General Meeting on June 11, 2026. This nomination, along with the proposed increase in Supervisory Board size from six to seven members, aims to strengthen the company's oversight and governance. Additionally, Evotec has entered into a cooperation agreement with key shareholder MAK Capital Fund LP, following constructive discussions. This agreement includes customary voting and cooperation commitments. The company views Dr. Hofmann's potential appointment as a contribution to additional industry, scientific, and governance expertise, complementing the existing Board structure and supporting Evotec's transformation plans for long-term value creation. MAK Capital expressed appreciation for the dialogue and welcomed the nomination, looking forward to continued collaboration to support Evotec's transformation.